SY
Stryker
SYK · NYSE
$303.12 -1.58% (-$4.87)
1M -10.59%
Market Cap $118.1B
P/E Ratio 31.66x
Div. Yield 1.13%
ROE 16.36%
Bulios Fair Price
$280.72
7.4% downside
Current Price
$303.12
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SYK is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
8/9Valuation
33 /100
Expensive EV/EBITDA 20.72x
P/S 4.57x
P/B 4.92x
Growth
77 /100
Growing Rev. growth 10.83%
FCF growth 28.13%
Book val. growth 10.50%
Profitability
94 /100
Strong Net margin 14.43%
Op. margin 22.03%
FCF margin 18.20%
Quality
62 /100
Average ROE 16.36%
ROA 7.78%
Asset turnover 0.54x
Debt
75 /100
Low Current ratio 2.16x
Int. coverage 7.73x
Net debt/EBITDA 1.85x
Stability
96 /100
Stable Rev. volatility 0.52%
EPS volatility 20.09%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SYK
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Kevin A. Lobo
Employees
56,000
Headquarters
Portage
Upcoming events
30 SEP
Ex-Dividend
Ex-dividend date
29 OCT
Earnings
Upcoming earnings report
30 OCT
Dividend Payment
Payment date